RecruitingNCT07618936

Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients

Sponsor

Tianjin Medical University

Enrollment

500 participants

Start Date

Jun 1, 2026

Study Type

OBSERVATIONAL

Conditions

PD-L1 Gene Mutation Positron Emission Tomography PD-L1 Gene Amplification PD-L1-related Disease

Summary

To evaluate the potential usefulness of 68Ga/18F-PD-L1 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various PD-L1-related disease patients

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Single Group Assignment for people with pd-l1 gene amplification, pd-l1 gene mutation, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.